TLOG (TetraLogic Pharmaceuticals) Current Accrued Expense: $3.68 Mil (As of Sep. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is TetraLogic Pharmaceuticals Current Accrued Expense?

TetraLogic Pharmaceuticals TLOG Current Accrued Expense is $3.68 Mil as of Sep. 2016.

TetraLogic Pharmaceuticals's Current Accrued Expense for the quarter that ended in Sep. 2016 was $3.68 Mil.

TetraLogic Pharmaceuticals's quarterly Current Accrued Expense declined from Mar. 2016 ($3.45 Mil) to Jun. 2016 ($1.93 Mil) but then increased from Jun. 2016 ($1.93 Mil) to Sep. 2016 ($3.68 Mil).

TetraLogic Pharmaceuticals's annual Current Accrued Expense increased from Dec. 2013 ($1.25 Mil) to Dec. 2014 ($2.33 Mil) and increased from Dec. 2014 ($2.33 Mil) to Dec. 2015 ($3.15 Mil).

TetraLogic Pharmaceuticals Current Accrued Expense Related Terms

TetraLogic Pharmaceuticals Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Current Accrued Expense Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Current Accrued Expense
1.93 1.61 1.25 2.33 3.15

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.58 3.15 3.45 1.93 3.68

TetraLogic Pharmaceuticals Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $3.68 Mil mean?
TetraLogic Pharmaceuticals (TLOG) has a Current Accrued Expense of $3.68 Mil as of Sep. 2016. Current Accrued Expense records the total amount of accrued expenses. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Current Accrued Expense too high?
TetraLogic Pharmaceuticals' current Current Accrued Expense is $3.68 Mil.
How does TetraLogic Pharmaceuticals' Current Accrued Expense compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Current Accrued Expense of $3.68 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Biotechnology company?
A good Current Accrued Expense depends on the Biotechnology industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Current Accrued Expense is $3.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Current Accrued Expense of $3.68 Mil. The current Current Accrued Expense is $3.68 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Current Accrued Expense is $3.68 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.